Logo
K

KromaTiD™ Inc.

33 employees

KromaTiD focuses on advancing the knowledge of genetic abnormalities and diseases by developing molecular cytogenetics assays and reagents.

Basic info

Industry

biotechnology research

Sectors

Developer Platform
Biotechnology
Gene Editing Process Optimization
Custom DNA Probes
Undiagnosed Disease Discovery
Genetic Disease Diagnosis
Chromatid and Chromosome Paint Products
Genetic Disease Screening
Chromosome Analysis
Gene Editing Off-Target Effects
Genetic Disease Discovery
CRISPR Analysis
Gene Editing Quality Control
Genetics
Medical
DNA Mutation Detection
Cell Culture Services
Biomedical Applications

Date founded

2007

Funding rounds raised

Total raised

$2M

from 2 investors over 2 rounds

K

KromaTiD™ Inc. raised $2M on April 28, 2021

Investors: BroadOak Capital Partners

K

KromaTiD™ Inc. raised undisclosed on August 13, 2019

Investors: First Capital Business Development, LLC.

FAQ